These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 9130253

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effects of chronic lithium treatment on serotonin binding sites in rat brain.
    Odagaki Y, Koyama T, Matsubara S, Matsubara R, Yamashita I.
    J Psychiatr Res; 1990; 24(3):271-7. PubMed ID: 2125080
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats.
    Gobbi M, Crespi D, Foddi MC, Fracasso C, Mancini L, Parotti L, Mennini T.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):22-8. PubMed ID: 9228186
    [Abstract] [Full Text] [Related]

  • 25. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain.
    Hall MD, el Mestikawy S, Emerit MB, Pichat L, Hamon M, Gozlan H.
    J Neurochem; 1985 Jun; 44(6):1685-96. PubMed ID: 3157780
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of chronic administration of interferon alpha A/D on serotonergic receptors in rat brain.
    Abe S, Hori T, Suzuki T, Baba A, Shiraishi H, Yamamoto T.
    Neurochem Res; 1999 Mar; 24(3):359-63. PubMed ID: 10215509
    [Abstract] [Full Text] [Related]

  • 29. Characterization of a novel serotonin receptor subtype (5-HT1S) in rat CNS: interaction with a GTP binding protein.
    Zemlan FP, Schwab EF.
    J Neurochem; 1991 Dec; 57(6):2092-9. PubMed ID: 1834802
    [Abstract] [Full Text] [Related]

  • 30. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA.
    Eur J Pharmacol; 2005 Mar 07; 510(1-2):49-57. PubMed ID: 15740724
    [Abstract] [Full Text] [Related]

  • 31. [3H]8-OH-DPAT labels the 5-hydroxytryptamine uptake recognition site and the 5-HT1A binding site in the rat striatum.
    Alexander BS, Wood MD.
    J Pharm Pharmacol; 1988 Dec 07; 40(12):888-91. PubMed ID: 2907586
    [Abstract] [Full Text] [Related]

  • 32. Apparent regional differences in 5-HT1A binding may reflect [3H]8-OH-DPAT labeling of serotonin uptake sites.
    Sprouse JS, McCarty DR, Dudley MW.
    Brain Res; 1993 Jul 16; 617(1):159-62. PubMed ID: 8374738
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT.
    Larsson LG, Rényi L, Ross SB, Svensson B, Angeby-Möller K.
    Neuropharmacology; 1990 Feb 16; 29(2):85-91. PubMed ID: 1691832
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The human 5-HT1A receptor: comparison of its binding properties in transfected cells and cortical tissue.
    Pou C, Nénonéné EK, Reader TA, Fargin A.
    Gen Pharmacol; 1997 Nov 16; 29(5):737-47. PubMed ID: 9347319
    [Abstract] [Full Text] [Related]

  • 38. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
    Emerit MB, Miquel MC, Gozlan H, Hamon M.
    J Neurochem; 1991 May 16; 56(5):1705-16. PubMed ID: 1826520
    [Abstract] [Full Text] [Related]

  • 39. Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT).
    Schlegel JR, Peroutka SJ.
    Biochem Pharmacol; 1986 Jun 15; 35(12):1943-9. PubMed ID: 3013203
    [Abstract] [Full Text] [Related]

  • 40. [3H]8-OH-DPAT labels a 5-HT site coupled to inhibition of phosphoinositide hydrolysis in the dorsal raphe.
    Johnson RG, Fiorella D, Winter JC, Rabin RA.
    Eur J Pharmacol; 1997 Jun 18; 329(1):99-106. PubMed ID: 9218690
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.